Drug search by name

Novo-Furan Suspension and G-6-PD deficiency

Result of checking the interaction of drug Novo-Furan Suspension and disease G-6-PD deficiency for safety when used together.

Check result:

Novo-Furan Suspension <> G-6-PD deficiency

Relevance: 23.07.2019 Reviewer: Shkutko P.M., M.D., in

When checking interaction based on authoritative sources Drugs.com, Rxlist.com, Webmd.com, Medscape.com there are contraindications or side effects that may cause harm or increase the negative effect from drug use in presence of concomitant diseases.

Consumer:

Hemolytic anemia has been reported in patients treated with nitrofurantoin, primarily in patients with glucose-6-phosphate dehydrogenase (G-6-PD) deficiency. Therapy with nitrofurantoin should be avoided or administered cautiously in patients with G-6-PD deficiency. The development of hemolysis is an indication for withdrawal of nitrofurantoin therapy. Hemolysis ceases when the drug is withdrawn.

References:

"Product Information. Macrobid (nitrofurantoin)." Procter and Gamble Pharmaceuticals, Cincinnati, OH.
"Product Information. Macrodantin (nitrofurantoin)." Procter and Gamble Pharmaceuticals, Cincinnati, OH.

Novo-Furan Suspension

Generic Name: nitrofurantoin

Brand Name: Furadantin, Macrobid, Macrodantin, Nitro Macro

Synonyms: Nitrofurantoin

What is Novo-Furan Suspension?